Overall rank by patents
#6,140
of 49,997 tracked assignees
USPTO PatentsView assignee record - 55 granted patents across 16 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).
The verdict
According to USPTO PatentsView, Enzo ranks #6,140 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 16 technology areas.
USPTO PatentsView assignee plate
Corpus R6140 · US Corporation #6,140 · 55 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Dental Imaging Technologies Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Bandai Namco… · near
43 score
Cal-comp BIG Data · near
43 score
Daishinku · near
43 score
Enzo Life Sciences · this assignee
43 score
Pierburg · near
43 score
3D Lighting… · lowest
7 score
What this shows Enzo's Innovation Score is 42.8/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Enzo Life Sciences, Inc. is a focused PatentsView assignee: 16 CPC subclasses with 85.5% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2016 (15 grants) versus a trough of 1 in 2023. By volume, Enzo sits between Dental Imaging Technologies Corporation and Entellus Medical, Inc..
Enzo Life Sciences, Inc. shows 4 grants in 2022–2024 against only 16 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Dental Imaging Technologies Corporation
55 patents
DT Swiss Inc.
55 patents
Dyax Corp.
55 patents
Elkay Manufacturing Company
55 patents
Eugene Technology Co., Ltd.
55 patents
East Carolina University
55 patents
Ellenberger & Poensgen GmbH
55 patents
Entellus Medical, Inc.
55 patents
Enzo Life Sciences, Inc.
55 patents
What this shows Enzo holds 55 patents at rank #6,137, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #6,137 in granted patent volume.
Other assignees with the most granted patents in Enzo's primary technology class.
Two PlainPatent-derived peer sets for Enzo, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (43 here).
Nearest assignees by average claims per patent (21.8 here).
Enzo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 30% higher than 70% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 7 | 12.7% |
| 2016 | 15 | 27.3% |
| 2017 | 8 | 14.5% |
| 2018 | 5 | 9.1% |
| 2019 | 5 | 9.1% |
| 2020 | 6 | 10.9% |
| 2021 | 5 | 9.1% |
| 2023 | 1 | 1.8% |
| 2024 | 3 | 5.5% |
Top 15 of 16 technology areas
Overall rank by patents
#6,140
of 49,997 tracked assignees
42.8 out of 100
What to do with this data
Enzo Life Sciences, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.